Optimal Delivery of Chemotherapeutic Agents in Cancer
|
|
- Madlyn Campbell
- 5 years ago
- Views:
Transcription
1 16th European Symposium on Computer Aided Process Engineering and 9th International Symposium on Process Systems Engineering W. Marquardt, C. Pantelides (Editors) 2006 Published by Elsevier B.V Optimal Delivery of Chemotherapeutic Agents in Cancer Pinky Dua a, Vivek Dua b, Efstratios N. Pistikopoulos a a Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, United Kingdom b Centre for Process Systems Engineering, Department of Chemical Engineering, University College London, Torrington Place, London WC1E 7JE, United Kingdom Abstract In this paper, derivation of the optimal chemotherapy schedule is formulated and solved as a dynamic optimization problem. For this purpose two models representing the tumour growth kinetics are considered. The dynamic optimization problem for the first model, which is cell cycle non-specific, takes into account multiple time characteristics, drug resistance and toxicity. The discontinuity in the model is formulated by introducing integer variables. For the second model, which is cell cycle specific, the tumour growth is modelled via two compartments: proliferating and resting compartment. Keywords: Drug Delivery Systems, Cancer, Chemotherapy, Optimal Control, Mixed Integer Dynamic Optimization 1. Introduction Cancer is a collective term that describes a group of diseases characterized by uncontrolled and unregulated growth of cells leading to invasion of surrounding tissues and spreading to the parts of the body that are distant from the site of origin. There are around 200 types of cancer and cancers of lungs, breast, bowel and prostrate are the most common ones. There are three main stages in the process of carcinogenesis: initiation, promotion and progression. The normal cell changes to an initiated cell and then to cancer differentiated cell and finally invades and spreads to the surrounding cells. The simplest mathematical model describes the entire cell cycle as a uniform entity, where all the cells contained in a tumour are of the same type. The cell cycle nonspecific models consist of one compartment so that the effect of the anticancer agents is same on all the cells. However these models fail to describe the action of cycle specific drugs due to their over-simplified nature. The more detailed multi-compartment models (cell cycle specific models) are considered for this purpose. Here the cell cycle is divided into compartments depending on the types of cells that are affected by the drug. Chemotherapy is one of the most commonly used treatments for cancer that uses anticancer or cytotoxic drugs to destroy or kill cancer cells. The suitability of chemotherapy and the choice of drugs depend on many factors including the type of cancer, the location of the origin of the cancer in the body, how mature the cancer cells are and whether the cancer cells have spread to the other parts of the body. Chemotherapy targets dividing cells which does not only include cancer cells but any
2 1644 P. Dua et al. normal cells that are dividing such as the hair producing cells, cells that line mouth and digestive system and those in the bone marrow and the skin. Harrold and Parker (2004) recently proposed a mixed integer linear programming approach for the derivation of optimal chemotherapy schedule. In this paper, optimal chemotherapy schedules are derived with the objective of minimizing the final number of tumour cells at the end of the treatment. The rest of the paper is orgainzed as follows: in Section 2 optimal cancer chemotherapy schedule is derived for a cell cycle non-specific model whereas a cell cycle specific model is considered in Section 3; concluding remarks are presented in Section Optimal Control for Cell Cycle non-specific Model A pharmacokinetic/pharmacodynamic model given in Martin (1992) is used for the derivation of the schedule. The objective is to obtain the drug dosage over a fixed period of time so as to minimize the number of cancer cells at the end of the period subject to constraints on toxicity and resistance of the drugs. The optimal control problem is formulated as follows: min J ( u) = z( T ) u, y s.t. z = λz( + k( υ( υ ) y z(0) = ln θ N 0 υ( = u( γυ( υ(0) = υ0 = 0 0 υ( υ, T υ( s) ds υ 0 max z(21) ln(200) z(42) ln(400) z(63) ln(800) υ( yυth, υ( υ ym, th cum th where u = [u 1,.,u n ] T R n is the vector of the rate of delivery of drug, z( is the nondimensional tumour size, λ is a growth parameter, k is the proportion of the tumour cells killed per unit time per unit drug concentration, υ( is the concentration of the anticancer drug at time t, υ th is the therapeutic concentration of the drug, y is a 0-1 binary variable, θ is the plateau population or the carrying capacity of the tumour, N 0 is the initial tumour cell population, υ max is the maximum amount of drug in the plasma, υ cum is the cumulative toxicity and M is a large positive number. Note that in this formulation the binary variable, y, is introduced to model the discontinuity so that y takes the value 0, if 0 υ( υ th, or the value 1, if υ( υ th and the following transformation is introduced to make the model tractable and tumour size dimensionless (Dua, 2005): z = ln ( θ ) N
3 Optimal Delivery of Chemotherapeutic Agents in Cancer 1645 where N is the number of tumour cells. The data for the parameters in the model is taken from Martin (1992). This problem is a mixed-integer dynamic optimization problem (Bansal et al., 2003) and is solved using gproms (gproms, 2003) by taking the control interval of one day and a time period of 84 days. The profiles of the optimal chemotherapy and tumour growth are shown in Figures 1 and 2 and are consistent with those reported in the open literature on optimal control strategies for cancer chemotherapy. Rate of Delivery of Drug ([D]/days) Figure 1 Optimal chemotherapy protocol for the cell cycle non specific model 1.2E E+10 Number of Cells 8.0E E E E E Figure 2 Predicted tumour growth using the optimal treatment protocol Initially no drug is delivered until the time approaches 21 days, the first interval of the multiple characteristic time constraints, z(21) ln(200), which are introduced to model
4 1646 P. Dua et al. drug resistance. This can be attributed to the fact that an initial high dose may not necessarily result in an overall decrease in the tumour size at the end of the time period as compared to the minimum tumour size obtained by the optimal chemotherapy protocol, while the constraints on toxicity and drug resistance are satisfied. Moreover, the drugs are given in large doses intermittently rather than in small doses continuously. The tumour follows the Gompertz growth until the first injection of the drug that results in a reduction of 70% of the initial tumour size. High intensity chemotherapy, from time 40 days till the end of the therapy, results in an increase in the rate of tumour reduction. The value of the objective function at the end of the treatment is given by cancer cells. As a conclusion, the optimal way to reduce the tumour size was to apply high intensity therapy towards the end of the chemotherapy period. The optimal chemotherapy protocol shown in Figure 1 produces a 99.9% reduction of the initial tumour size. 3. Optimal Control for Cell Cycle Specific Model The model of Panetta and Adam (1995) describes the administration of the anticancer drug in the case of cell cycle specific chemotherapy. In this model, the effect of the drug depends only on the duration of the injection and not on the amount of the drug that is injected. For this reason, this model is modified so as to relate the effect of the drug with the rate of delivery of the drug (Dua, 2005) and minimization of the final tumour population is formulated as the following optimal control problem: min J ( u) = P( T ) + Q( T ) u( s.t. P = ( a m n) P( + bq( g( P(, Q = mp( bq(, y( y = δy( 1 g( y(, K υ( = u( γυ1(, g( = k1υ 1( ymin y( K, P(0) = P0 Q(0) = Q0 y(0) = y0 υ1(0) = υ0 where P and Q represent the cycling and non-cycling tumour cell mass respectively, a is the cycling cell growth rate, m is the rate at which cycling cells become non-cycling, n is the natural decay of cycling cells, b is the rate at which non-cycling cells become cycling, y is the number of normal cells, δ is the growth rate, K is the carrying capacity of normal tissue, g is the effect of drug on the cells, υ 1 is the concentration of the drug in the body, u is the rate of the delivery of the drug, k 1 is the parameter for the kill rate and γ is the parameter for the decay of the drug. The parameters for this model are taken from Panetta and Adam (1995). The problem was solved by using gproms by considering a time horizon of 60 days and control interval of one day. The optimal chemotherapy schedule derived is shown in Figure 3. Initially, the drug is delivered at a high dose, followed by a low intensity therapy for almost the rest of the treatment period. Finally, a large amount of drug is applied in the last two days. The objective function represents the size of the tumour, including both the proliferating (cycling) and resting (non-cycling) compartments. The
5 Optimal Delivery of Chemotherapeutic Agents in Cancer 1647 evolution of number of cancer cells during the therapy period is illustrated in Figure 4. After the optimal drug protocol is applied to the patient, the predicted number of cancer cells drops from cells to cells, which corresponds to 60% reduction of the initial tumour size. The final reduction in the number of cancer cells is less when compared to the results obtained for the cell cycle non-specific case. Nevertheless, the cell cycle specific model includes the constraint that places strict limits to the acceptable number of normal cells, i.e. y min = As shown in Figure 5, for almost the entire treatment period, the level of normal cells is near to its lower bound. It is obvious that the first high dose of the drug had an enormous effect on normal cells, which did not allow further application of high doses, apart from that in the last two days. Rate of Delivery of Drug ([D]/days) Figure 3 Optimal chemotherapy protocol for the cell cycle specific model 1.2E E+12 Number of Cells 8.0E E E E E Figure 4 Predicted tumour growth using the optimal treatment protocol cycling and non-cycling cells
6 1648 P. Dua et al. Number of Cells 1.2E E E E E E E Figure 5 Predicted growth of the normal cell population using the optimal treatment protocol 4. Concluding Remarks In this paper, two models for the derivation of optimal chemotherapy schedules were considered. The first model involves the use of cell cycle non-specific agents. The tumour is modelled as one compartment and the drug is assumed to affect all the cancer cells in the same way. Toxicity to normal cells is controlled with constraints that limit drug concentration during therapy, as well as the total cumulative toxicity at the end of the treatment. The problem is formulated and solved as a mixed integer dynamic optimization problem. The optimal chemotherapy protocol derived in this case kept the initial administration of the drug at a low level, while most of the drug was delivered towards the end of the therapy. The second model describes the effects of the cell cycle specific drugs. The tumour is divided into two compartments; the cycling and the noncycling compartments. Toxicity is monitored through the differential equation that describes the effect of the drug on normal cell population. The problem is formulated and solved as a dynamic optimization problem. The optimal chemotherapy indicates that the anticancer agent should be administered in high doses at the beginning and at the end of the treatment period. The current work involves formulating these problems such that the objective is not only to minimize the tumour size at the end of a given time period but also to optimize the time period for the therapy. References V. Bansal, V. Sakizlis, R. Ross, J.D. Perkins and E.N. Pistikopoulos, 2003, New algorithms for mixed integer dynamic optimization, Computers and Chemical Engineering, 27, P. Dua, 2005, Model based and parametric control for drug delivery systems, PhD Thesis, Imperial College London, University of London gproms, 2003, Introductory User s Guide, Release 2.2, Process Systems Enterprise Limited, London, U. K. J.M. Harrold and R.S. Parker, 2004, An MILP approach to cancer chemotherapy dose regime design, Proc. American Control Conference, R.B. Martin, 1992, Optimal control drug scheduling of cancer chemotherapy, Automatica, 28, J.C. Panetta and J. Adam, 1995, A mathematical model of cycle-specific chemotherapy, Mathematical and Computer Modelling, 22, 67-82
Optimizing Drug Regimens in Cancer Chemotherapy
Optimizing Drug Regimens in Cancer Chemotherapy A. ILIADIS, D. BARBOLOSI Department of Pharmacokinetics, Faculty of Pharmacy University of Méditerranée 27, bld. Jean Moulin, 13385 Marseilles Cedex 5 FRANCE
More informationMOGA-based Multi-drug Optimisation for Cancer Chemotherapy
MOGA-based Multi-drug Optimisation for Cancer Chemotherapy S Algoul, M S Alam*, K Sakib, M A Hossain and M A A Majumder University of Bradford, Bradford, UK, *University of Dhaka, Bangladesh {S.K.A.Algoul,k.muheymin-us-sakib;
More informationA survey of optimization models on cancer chemotherapy treatment planning
DOI 10.1007/s10479-011-0869-4 A survey of optimization models on cancer chemotherapy treatment planning Jinghua Shi Oguzhan Alagoz Fatih Safa Erenay Qiang Su Springer Science+Business Media, LLC 2011 Abstract
More informationIMMUNOLOGICAL SURVEILLANCE AND NEOPLASTIC DEVELOPMENT
ROCKY MOUNTAIN JOURNAL OF MATHEMATICS Volume 9, Number 1, Winter 1979 IMMUNOLOGICAL SURVEILLANCE AND NEOPLASTIC DEVELOPMENT GEORGE W. SWAN 1. Introduction. In 1908 Ehrlich suggested that one of the functions
More informationBY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,
More informationCancer Treatment Using Multiple Chemotheraputic Agents Subject to Drug Resistance
Cancer Treatment Using Multiple Chemotheraputic Agents Subject to Drug Resistance J. J. Westman Department of Mathematics University of California Box 951555 Los Angeles, CA 90095-1555 B. R. Fabijonas
More informationMathematics Meets Oncology
.. Mathematics Meets Oncology Mathematical Oncology Philippe B. Laval Kennesaw State University November 12, 2011 Philippe B. Laval (Kennesaw State University)Mathematics Meets Oncology November 12, 2011
More informationAnticancer Drugs. University of Sulaimani Faculty of Medical Sciences School of Pharmacy Pharmacology & Toxicology Dept.
University of Sulaimani Faculty of Medical Sciences School of Pharmacy Pharmacology & Toxicology Dept. Anticancer Drugs Prepared by: Hussein A. Muhammad MSc cancer Pharmacology hussein.al-barazanchi@kissr.edu.krd
More informationarxiv: v1 [q-bio.to] 17 Apr 2016
Optimized Treatment Schedules for Chronic Myeloid Leukemia Qie He 1, Junfeng Zhu 1, David Dingli 2, Jasmine Foo 3**, Kevin Leder 2*, arxiv:1604.04913v1 [q-bio.to] 17 Apr 2016 1 Department of Industrial
More informationarxiv: v2 [math.oc] 15 Nov 2016
Optimizing chemoradiotherapy to target multi-site metastatic disease and tumor growth arxiv:1603.00349v2 [math.oc] 15 Nov 2016 Hamidreza Badri, 1 Ehsan Salari, 2 Yoichi Watanabe, 3 Kevin Leder 1 1 Department
More informationTreatment Planning of Cancer Dendritic Cell Therapy Using Multi-Objective Optimization
Treatment Planning of Cancer Dendritic Cell Therapy Using Multi-Objective Optimization K. Lakshmi Kiran*, S. Lakshminarayanan* *Department of Chemical and Biomolecular Engineering, National University
More informationThe Chemostat: Stability at Steady States. Chapter 5: Linear & Non-Linear Interaction Models. So, in dimensional form, α 1 > 1 corresponds to
Introduction & Simple Models Logistic Growth Models The Chemostat: Stability at Steady States 1 So, in dimensional form, α 1 > 1 corresponds to K max < V F. As K max is max bacterial repro rate with unlimited
More informationIntroduction to Basic Oncology
Introduction to Basic Oncology Cancer Cell AHS 102 Med Term Dr. Susie Turner 1/3/13 General Oncology Study of Tumors Neoplasms/Tumors Abnormal growth of new tissue Are either; Benign or Malignant Onc/o
More informationInsulin Administration for People with Type 1 diabetes
Downloaded from orbit.dtu.dk on: Nov 17, 1 Insulin Administration for People with Type 1 diabetes Boiroux, Dimitri; Finan, Daniel Aaron; Poulsen, Niels Kjølstad; Madsen, Henrik; Jørgensen, John Bagterp
More informationGenetic Algorithm for Solving Simple Mathematical Equality Problem
Genetic Algorithm for Solving Simple Mathematical Equality Problem Denny Hermawanto Indonesian Institute of Sciences (LIPI), INDONESIA Mail: denny.hermawanto@gmail.com Abstract This paper explains genetic
More information1.3 Targeting Therapeutics
cytotoxics and hormone based. Cytotoxins assault DNA at some level, either in its synthesis, replication or processing (Denny, 2001). Cytotoxins can be further split into: alkylating agents e.g. cyclophosphamide;
More informationMODELING OF THE CARDIOVASCULAR SYSTEM AND ITS CONTROL MECHANISMS FOR THE EXERCISE SCENARIO
MODELING OF THE CARDIOVASCULAR SYSTEM AND ITS CONTROL MECHANISMS FOR THE EXERCISE SCENARIO PhD Thesis Summary eng. Ana-Maria Dan PhD. Supervisor: Prof. univ. dr. eng. Toma-Leonida Dragomir The objective
More informationModeling of cancer virotherapy with recombinant measles viruses
Modeling of cancer virotherapy with recombinant measles viruses Thomas W. Carr Department of Mathematics Southern Methodist University Dallas, TX Collaborators: Krešimir Josić Dept. of Mathematics, University
More informationInterventional Oncology Patient Awareness
Interventional Oncology Patient Awareness Interventional Radiology: your minimally invasive alternative www.cirse.org Cardiovascular and Interventional Radiological Society of Europe Cardiovascular and
More informationWeather Cancer. Problem: Wanted: prediction But: difficult Why? Complex systems, i.e. many agents agents, feedback dynamics.
Weather Cancer Financial markets Problem: Wanted: prediction But: difficult Why? Complex systems, i.e. many agents agents, feedback dynamics ? Analyzing emergent behaviour in cellular automaton models
More informationMathematical Model of Vaccine Noncompliance
Valparaiso University ValpoScholar Mathematics and Statistics Faculty Publications Department of Mathematics and Statistics 8-2016 Mathematical Model of Vaccine Noncompliance Alex Capaldi Valparaiso University
More informationMathematical Modeling for the Tumor Growth in the Bladder
IJISET - International Journal of Innovative Science, Engineering & Technology, Vol. 2 Issue 5, May 25. Mathematical Modeling for the Tumor Growth in the Bladder L. N. M. Tawfiq & S. A. Abdul-Jabbar Department
More informationThe effect of infectiousness, duration of sickness, and chance of recovery on a population: a simulation study
Research Article The effect of infectiousness, duration of sickness, and chance of recovery on a population: a simulation study McKayla Johnson, Tashauna Gilliam, and Istvan Karsai East Tennessee State
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More informationChallenges in Synthesis of Optimal Controls For Problems Arising in Biomedicine
Challenges in Synthesis of Optimal Controls For Problems Arising in Biomedicine ITN SADCO meeting January 21-25, 2013, Funchal, Portugal Urszula Ledzewicz Dept. of Mathematics and Statistics Southern Illinois
More informationImproved Outer Approximation Methods for MINLP in Process System Engineering
Improved Outer Approximation Methods for MINLP in Process System Engineering Lijie Su, Lixin Tang, Ignacio E. Grossmann Department of Chemical Engineering, Carnegie Mellon University 1 Outline MINLP is
More informationLecture 10: Learning Optimal Personalized Treatment Rules Under Risk Constraint
Lecture 10: Learning Optimal Personalized Treatment Rules Under Risk Constraint Introduction Consider Both Efficacy and Safety Outcomes Clinician: Complete picture of treatment decision making involves
More informationCANCER TREATMENT. Sent from the Diagnostic Imaging Atlas Page 1 of 5
CANCER TREATMENT When cancer is diagnosed in a pet continuous improvements in our knowledge and new and evolving methods of treatment give options to owners and their veterinarians. These notes are provided
More informationAppendix (unedited, as supplied by the authors)
Appendix (unedited, as supplied by the authors) Details of the mathematical model The model used for the simulations in this manuscript was adapted from a previously described model of HCV transmission
More informationStatistical modelling of primary Ewing tumours of the bone
Statistical modelling of primary Ewing tumours of the bone Sreepurna Malakar Department of Chemistry and Biochemistry University of Alaska, U.S.A. Florentin Smarandache Department of Mathematics and Statistics
More informationA Monogenous MBO Approach to Satisfiability
A Monogenous MBO Approach to Satisfiability Hussein A. Abbass University of New South Wales, School of Computer Science, UC, ADFA Campus, Northcott Drive, Canberra ACT, 2600, Australia, h.abbass@adfa.edu.au
More informationThe Immune System & Non- Infectious Disease. Ch. 18: Sections 1, 2, & 4
The Immune System & Non- Infectious Disease Ch. 18: Sections 1, 2, & 4 What is the Immune System? The purpose of the immune system is to: keep infectious microorganisms, such as certain bacteria, viruses,
More informationWEIGHTED GOAL PROGRAMMING MODEL FORMULATION AND CALCULATION OF DIET PLANNING
CHAPTER III WEIGHTED GOAL PROGRAMMING MODEL FORMULATION AND CALCULATION OF DIET PLANNING 3.1 INTRODUCTION Linear goal programming is one of many techniques for dealing with the modeling, solution, and
More informationSummary of Evolution and the Requirements for the Specific Cure of Cancer
Summary of Evolution and the Requirements for the Specific Cure of Cancer The definition of cancer Cancer is defined by malignant behavior, (e.g. cell proliferation and invasiveness in an abnormal context.
More informationMathematical modelling of spatio-temporal glioma evolution
Papadogiorgaki et al. Theoretical Biology and Medical Modelling 213, 1:47 RESEARCH Open Access Mathematical modelling of spatio-temporal glioma evolution Maria Papadogiorgaki 1*, Panagiotis Koliou 2, Xenofon
More information- is a common disease - 1 person in 3 can expect to contract cancer at some stage in their life -1 person in 5 can expect to die from it
MBB157 Dr D Mangnall The Molecular Basis of Disease CANCER Lecture 1 One of the simpler (and better) definitions of cancer comes from the American Cancer Society, who define cancer as; 'Cancer is a group
More information"The standard treatment for almost all cancers is surgical removal of the lump."
Cancer Treatment As continuous improvements in our knowledge and new and evolving methods of treatment are developed, pet owners and their veterinarians have more options available when cancer is diagnosed.
More informationStructured models for dengue epidemiology
Structured models for dengue epidemiology submitted by Hannah Woodall for the degree of Doctor of Philosophy of the University of Bath Department of Mathematical Sciences September 24 COPYRIGHT Attention
More informationMathematical models of tumor growth and radiation response
Mathematical models of tumor growth and radiation response Yoichi Watanabe, Ph.D. Department of Radiation Oncology University of Minnesota North Central Chapter of AAPM Meeting, Wisconsin Dells, WI April
More informationModeling Multi-Mutation And Drug Resistance: A Case of Immune-Suppression
Global Journal of Pure and Applied Mathematics. ISSN 0973-1768 Volume 14, Number 6 (2018), pp. 787-807 Research India Publications http://www.ripublication.com/gjpam.htm Modeling Multi-Mutation And Drug
More informationA New Bivariate Class of Life Distributions
Applied Mathematical Sciences, Vol. 7, 2013, no. 2, 49-60 A New Bivariate Class of Life Distributions Zohdy M. Nofal Department of Statistics, Mathematics and Insurance Faculty of Commerce, Benha University,
More informationImmune System. Before You Read. Read to Learn
Immune System 37 section 2 The Immune System Biology/Life Sciences 10.b Students know the role of antibodies in the body s response to infection. Also covers: Biology/Life Sciences 10.a, 10.e, 10.f Components
More informationMMCS Turkey Flu Pandemic Project
MMCS Turkey Flu Pandemic Project This is a group project with 2 people per group. You can chose your own partner subject to the constraint that you must not work with the same person as in the banking
More information35.2 Defenses against Infection
35.2 Defenses against Infection Key Questions At the end of this section you should be able to answer the following questions: What are the two types of infections? What are examples of each? How does
More informationUse of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.
Radiation Therapy Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation. One person in three will develop some form of cancer in their lifetime.
More informationPattern formation during effector and memory immune responses to cancer
Pattern formation during effector and memory immune responses to cancer Raluca Eftimie Division of Mathematics University of Dundee, UK reftimie@maths.dundee.ac.uk June, 2016 Why effector& memory immune
More informationNormal Cell Growth and Development
Normal Cell Growth and Development Noncancerous Versus Cancerous Tumors Cancerous Cell Growth and Development Cancer Genetics Causes of Cancer Epidemiology of Cancer Types of Cancer Resources Normal Cell
More informationCancer arises from the mutation of a normal gene. A factor which brings about a mutation is called a mutagen.
Cancer Single cells divide by mitosis to form many cells. This cells undergo physical and chemical changes in order to perform specific functions. (we say the cells have Differentiated) in this way we
More informationAnalyzing Immunotherapy and Chemotherapy of Tumors through Mathematical Modeling Summer Student-Faculty Research Project
Analyzing Immunotherapy and Chemotherapy of Tumors through Mathematical Modeling Summer Student-Faculty Research Project by Lisette de Pillis, Weiqing Gu, William Chang, Lindsay Crowl, Eric Malm, Katherine
More informationAcute: Symptoms that start and worsen quickly but do not last over a long period of time.
Cancer Glossary Acute: Symptoms that start and worsen quickly but do not last over a long period of time. Adjuvant therapy: Treatment given after the main treatment. It usually refers to chemotherapy,
More informationRadiobiological principles of brachytherapy
Radiobiological principles of brachytherapy Low dose rate (LDR) Medium dose rate (MDR) High dose rate (HDR) The effect of dose rate As the dose rate is decreased, there is more time during irradiation
More informationRadiation Therapy. This reference summary reviews what to expect during and after radiation therapy.
Radiation Therapy Introduction Radiation therapy is a very common treatment for a variety of cancers. Radiation therapy, also called radiotherapy, is a cancer treatment that uses high doses of radiation
More informationAn Adaptive Multimeme Algorithm for Designing HIV Multidrug Therapies
1 An Adaptive Multimeme Algorithm for Designing HIV Multidrug Therapies Ferrante Neri, Student Member, IEEE, Jari Toivanen, Giuseppe L. Cascella, Member, IEEE,Yew-Soon Ong, Member, IEEE Department of Mathematical
More informationImproving Envelopment in Data Envelopment Analysis by Means of Unobserved DMUs: An Application of Banking Industry
Journal of Quality Engineering and Production Optimization Vol. 1, No. 2, PP. 71-80, July Dec. 2015 Improving Envelopment in Data Envelopment Analysis by Means of Unobserved DMUs: An Application of Banking
More informationBiochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval
Biochemistry of Carcinogenesis Lecture # 35 Alexander N. Koval What is Cancer? The term "cancer" refers to a group of diseases in which cells grow and spread unrestrained throughout the body. It is difficult
More informationOutline. 1 Introduction. 2 Topic 1: Information Processing. 3 Topic 2: Information Aggregation
Big Picture: Human-robot decision dynamics Optimization Strategies for Cognition and Autonomy in Mixed Human-Robot Teams Vaibhav Srivastava and Francesco Bullo Center for Control, Dynamical Systems & Computation
More informationBMBF Forsys Partner Project: A Systems Biology Approach towards Predictive Cancer Therapy
ling and ling and BMBF Forsys Partner Project: A Systems Biology Approach towards Predictive Cancer Therapy H. Perfahl, A. Lapin, M. Reuss Germany holger.perfahl@ibvt.uni-stuttgart.de 1 ling and Cooperation
More informationPubH 7405: REGRESSION ANALYSIS
PubH 7405: REGRESSION ANALYSIS APLLICATIONS B: MORE BIOMEDICAL APPLICATIONS #. SMOKING & CANCERS There is strong association between lung cancer and smoking; this has been thoroughly investigated. A study
More informationCounteracting Novelty Decay in First Story Detection
Counteracting Novelty Decay in First Story Detection Yumeng Qin 1, Dominik Wurzer 2, Victor Lavrenko 2, and Cunchen Tang 1 1 Wuhan University - International School of Software 2 Edinburgh University -
More informationMathematical Model Solid Tumor at the Stage of Angiogenesis with Immune Response
Mathematical Model Solid Tumor at the Stage of Angiogenesis with Immune esponse Deep Shikha Dixit, Deepak Kumar, Sanjeev Kr,ajesh Johri. Department of Mathematics, CET IILM, Gr. Noida.. Department of Mathematics,
More informationTumor Migration Analysis. Mohammed El-Kebir
Tumor Migration Analysis Mohammed El-Kebir samples Mutation Matrix mutations Standard hylogenetic Techniques Sample Tree 0 1 1 0 1 0 1 * @ 1 1 0 1 0A Cellular History of Metastatic Cancer * mutation 1
More informationAnalysis of glucose-insulin-glucagon interaction models.
C.J. in t Veld Analysis of glucose-insulin-glucagon interaction models. Bachelor thesis August 1, 2017 Thesis supervisor: dr. V. Rottschäfer Leiden University Mathematical Institute Contents 1 Introduction
More informationBiological Therapies for Cancer: Questions and Answers
Biological Therapies for Cancer: Questions and Answers Key Points Biological therapies use the body s immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments
More informationChapter 22: The Lymphatic System and Immunity
Bio40C schedule Lecture Immune system Lab Quiz 2 this week; bring a scantron! Study guide on my website (see lab assignments) Extra credit Critical thinking questions at end of chapters 5 pts/chapter Due
More informationAn Evolutionary Approach to Cancer Chemotherapy Scheduling
An Evolutionary Approach to Cancer Chemotherapy Scheduling Gabriela Ochoa Minaya Villasana Edmund K. Burke Abstract In this paper, we investigate the employment of evolutionary algorithms as a search mechanism
More informationOverview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology
Overview of Cancer Mylene Freires Advanced Nurse Practitioner, Haematology Aim of the Presentation Review basic concepts of cancer Gain some understanding of the socio-economic impact of cancer Order of
More informationDesign and Simulation of Blocked Blood Vessel for Early Detection of Heart Diseases
Proceedings of the 215 2nd International Symposium on Physics and Technology of Sensors, 8-1th March, 215, Pune, India Design and Simulation of Blocked Blood Vessel for Early Detection of Heart Diseases
More informationThe effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells
The effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells Published in: Natl Med J China, February 10, 2003; Vol 83, No 3, Page 195-197. Authors: JIAO Shun-Chang,
More informationLabor Dr. Gansauge Sedanstraße, Ulm
Labor Dr. Gansauge Sedanstraße, Ulm 3 3 LANEX-DC Immunotherapy with dendritic cells The ability to fight cancer using one s own immune system has been a great dream of medical scientists for centuries.
More informationStrategic Level Proton Therapy Patient Admission Planning: A Markov Decision Process Modeling Approach
University of New Haven Digital Commons @ New Haven Mechanical and Industrial Engineering Faculty Publications Mechanical and Industrial Engineering 6-2017 Strategic Level Proton Therapy Patient Admission
More informationCatch-up Scheduling for Childhood Immunization
Catch-up Scheduling for Childhood Immunization Faramroze Engineer 1 Pinar Keskinocak 2 Larry Pickering 3 1 University of Newcastle 2 Georgia Institute of Technology 3 Centers of Disease Control and Prevention
More informationCLASSIFICATION OF BRAIN TUMOUR IN MRI USING PROBABILISTIC NEURAL NETWORK
CLASSIFICATION OF BRAIN TUMOUR IN MRI USING PROBABILISTIC NEURAL NETWORK PRIMI JOSEPH (PG Scholar) Dr.Pauls Engineering College Er.D.Jagadiswary Dr.Pauls Engineering College Abstract: Brain tumor is an
More informationSupplementary data for:
Supplementary data for: Prediction of treatment efficacy for prostate cancer using a mathematical model Huiming Peng 1, Weiling Zhao 1, Hua Tan 1, Zhiwei Ji 1, Jingsong Li 2, King Li 1, Xiaobo Zhou 1,*
More informationChapter 3. Neoplasms. Copyright 2015 Cengage Learning.
Chapter 3 Neoplasms Terminology Related to Neoplasms and Tumors Neoplasm New growth Tumor Swelling or neoplasm Leukemia Malignant disease of bone marrow Hematoma Bruise or contusion Classification of Neoplasms
More informationTUMOR cells can be divided into proliferating or cycling
Heuristic design of cancer chemotherapies Minaya Villasana, Gabriela Ochoa Abstract A methodology using heuristic search methods is proposed for optimizing cancer chemotherapies with drugs acting on a
More informationA parallel algorithm for optimal job shop scheduling of semi-constrained details processing on multiple machines
INSTITUTE OF INFORMATION AND COMMUNICATION TECHNOLOGIES BULGARIAN ACADEMY OF SCIENCE A parallel algorithm for optimal job shop scheduling of semi-constrained details processing on multiple machines Daniela
More informationSimulating the Tumor Growth with Cellular Automata Models
Simulating the Tumor Growth with Cellular Automata Models S. Zouhri Université Hassan II- Mohammédia, Faculté des Sciences Ben M'sik Département de Mathématiques, B.7955, Sidi Othmane, Casablanca, Maroc
More informationToward Comparison-based Adaptive Operator Selection
Toward Comparison-based Adaptive Operator Selection Álvaro Fialho, Marc Schoenauer, Michèle Sebag Orsay, France Evolutionary Algorithms cycle and parameters Performance very sensitive to the parameter
More informationTherapeutic ratio - An Overview. Past Present Future Prof Ramesh S Bilimaga
Therapeutic ratio - An Overview Past Present Future Prof Ramesh S Bilimaga Radiation Oncology Discipline of human medicine concerned with the generation, conservation and dissemination of knowledge concerning
More informationPage 4: Antigens: Self-Antigens The body has a vast number of its own antigens called self-antigens. These normally do not trigger immune responses.
Common Characteristics of B and T Lymphocytes Graphics are used with permission of Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.com). Page 1: Introduction While B and T lymphocytes
More informationOutline. Model Development GLUCOSIM. Conventional Feedback and Model-Based Control of Blood Glucose Level in Type-I Diabetes Mellitus
Conventional Feedback and Model-Based Control of Blood Glucose Level in Type-I Diabetes Mellitus Barış Ağar, Gülnur Birol*, Ali Çınar Department of Chemical and Environmental Engineering Illinois Institute
More informationOptimisation of cancer drug treatments using cell population dynamics
Optimisation of cancer drug treatments using cell population dynamics Frédérique Billy 1, Jean Clairambault 1, and Olivier Fercoq 2 1 INRIA BANG team, BP 105, F78153 Rocquencourt, and LJLL, UPMC, 4 Place
More informationGenetic Algorithms and their Application to Continuum Generation
Genetic Algorithms and their Application to Continuum Generation Tracy Moore, Douglass Schumacher The Ohio State University, REU, 2001 Abstract A genetic algorithm was written to aid in shaping pulses
More informationUltrasound Guided HIFU Ablation (USgFUS)
Ultrasound Guided HIFU Ablation (USgFUS) Mark Carol, M.D. Chief Development Officer SonaCare Medical AAPM 2013 SONACARE Sonablate Multi-Functional HIFU Probe See, Treat, and Track See Treat Track 3 HIFU
More informationDiagnosis of Liver Tumor Using 3D Segmentation Method for Selective Internal Radiation Therapy
Diagnosis of Liver Tumor Using 3D Segmentation Method for Selective Internal Radiation Therapy K. Geetha & S. Poonguzhali Department of Electronics and Communication Engineering, Campus of CEG Anna University,
More informationBIT 120. Copy of Cancer/HIV Lecture
BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations
More informationCervical Cancer Treatment
Scan for mobile link. Cervical Cancer Treatment Cervical cancer overview Cervical cancer occurs in the cervix, the part of the female reproductive system that connects the vagina and uterus. Almost all
More informationCausation Issues. Delay in Diagnosis of Cancer Cases. Prof Pat Price Imperial College London
Causation Issues Delay in Diagnosis of Cancer Cases Prof Pat Price Imperial College London office@patprice.co.uk www.patprice.co.uk Faculty of Advocates Annual conference 18 th June 2018 EVIDENCE BASED
More informationarxiv: v3 [q-bio.to] 9 Apr 2009
MATHEMATICAL BIOSCIENCES AND ENGINEERING Volume xx, Number 0xx, xx 20xx http://www.mbejournal.org/ pp. 1 xx A SPATIAL MODEL OF TUMOR-HOST INTERACTION: APPLICATION OF CHEMOTHERAPY arxiv:0810.1024v3 [q-bio.to]
More informationChapter 3: Linear & Non-Linear Interaction Models
Chapter 3: 155/226 Chapter develops the models above to examine models which involve interacting species or quantities. Models lead to simultaneous differential equations for coupled quantites due to the
More informationAssignment Question Paper I
Subject : - Discrete Mathematics Maximum Marks : 30 1. Define Harmonic Mean (H.M.) of two given numbers relation between A.M.,G.M. &H.M.? 2. How we can represent the set & notation, define types of sets?
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationSCHOOL OF MATHEMATICS AND STATISTICS
Data provided: Tables of distributions MAS603 SCHOOL OF MATHEMATICS AND STATISTICS Further Clinical Trials Spring Semester 014 015 hours Candidates may bring to the examination a calculator which conforms
More informationShift Design with Answer Set Programming
Shift Design with Answer Set Programming LPNMR 2015 Michael Abseher TU Wien, Vienna, Austria Martin Gebser University of Potsdam, Potsdam, Germany Nysret Musliu TU Wien, Vienna, Austria Torsten Schaub
More informationThe Pressure Losses in the Model of Human Lungs Michaela Chovancova, Pavel Niedoba
The Pressure Losses in the Model of Human Lungs Michaela Chovancova, Pavel Niedoba Abstract For the treatment of acute and chronic lung diseases it is preferred to deliver medicaments by inhalation. The
More informationLIFE ONE cancer/aids treatment
Nine Lives Press Release August 23, 2006 LIFE ONE cancer/aids treatment Nine Lives C.A./ 0412.234-0234 HOPE HAS A NEW NAME By: Dr. José Benavente Director of Public Health Valencia, Carabobo Venezuela
More informationLecture 13: Finding optimal treatment policies
MACHINE LEARNING FOR HEALTHCARE 6.S897, HST.S53 Lecture 13: Finding optimal treatment policies Prof. David Sontag MIT EECS, CSAIL, IMES (Thanks to Peter Bodik for slides on reinforcement learning) Outline
More informationResearch Article An Improved Approach for Reduction of Defect Density Using Optimal Module Sizes
So ware Engineering, Article ID 803530, 7 pages http://dx.doi.org/10.1155/2014/803530 Research Article An Improved Approach for Reduction of Defect Density Using Optimal Module Sizes Dinesh Verma and Shishir
More informationA mathematical model of tumor dynamics during stereotactic body radiation therapy for non-small cell lung cancer
A mathematical model of tumor dynamics during stereotactic body radiation therapy for non-small cell lung cancer Russell Injerd, Emma Turian Abstract Image guided radiotherapy allows tumor volume dynamics
More information